North America Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR745
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Blood is an essential requirement for health care which helps in the proper functioning of the human body. A blood screening is defined as a medical process for the detection of disease. The process of blood screening is carried out for a variety of reasons in which the most common reason is pregnancy, human immunodeficiency (HIV) and blood type screenings. Screening of the blood may also be done to detect conditions such as general infections and cancer. Different types of assays are performed in detecting health related problems. Collected blood is screened with different techniques such as ELISA, NAT technology, next generation sequencing and many others. EIAs, particle agglutination (rapid tests) and (Chemiluminescence Immunoassays) CLIAs assays are used for blood screening. Most (Chemiluminescence Immunoassays) CLIAs consists greater specificity and sensitivity as compare to rapid tests that provides better result in screening process.

North America blood screening market is expected to reach healthy CAGR of 9.6% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation

By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.

In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.

In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today's world. The Blood screening method is found to be more useful for detecting cancer.

In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.

The key market players for North America blood screening market are listed below:

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 29

1.1 OBJECTIVES OF THE STUDY 29

1.2 MARKET DEFINITION 29

1.3 OVERVIEW OF NORTH AMERICA BLOOD SCREENING MARKET 29

1.4 CURRENCY AND PRICING 30

1.5 LIMITATION 31

1.6 MARKETS COVERED 31

2 MARKET SEGMENTATION 35

2.1 MARKETS COVERED 35

2.2 GEOGRAPHIC SCOPE 36

2.3 YEARS CONSIDERED FOR THE STUDY 37

2.4 CURRENCY AND PRICING 37

2.5 RESEARCH METHODOLOGY 38

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41

2.7 DBMR MARKET POSITION GRID 42

2.8 THE CATEGORY VS TIME GRID 43

2.9 THE CATEGORY VS TIME GRID 44

2.10 DBMR MARKET CHALLENGE MATRIX 45

2.11 SECONDARY SOURCES 46

2.12 ASSUMPTIONS 46

3 MARKET OVERVIEW 47

3.1 DRIVERS 49

3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS 49

3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES 49

3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS 50

3.2 RESTRAINTS 51

3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES 51

3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS 51

3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES 52

3.3 OPPORTUNITIES 53

3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING 53

3.4 CHALLENGES 54

3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT 54

4 EXECUTIVE SUMMARY 55

5 PREMIUM INSIGHTS 59

6 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES 61

6.1 OVERVIEW 62

6.2 REAGENTS & KITS 64

6.2.1 ELISA REAGENTS & KITS 66

6.2.1.1 IMMUNOSORBENTS 67

6.2.1.2 CONJUGATES 67

6.2.1.3 SUBSTRATES 67

6.2.1.4 CONTROLS 67

6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS 67

6.2.2 NAT REAGENTS & KITS 67

6.2.2.1 PROBES AND PRIMERS 68

6.2.2.2 ENZYMES AND POLYMERASES 68

6.2.2.3 LABELING AND DETECTION REAGENTS 68

6.2.2.4 STANDARDS AND CONTROLS 68

6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS 68

6.3 INSTRUMENTS 69

6.3.1.1 INSTRUMENTS, PRODUCT TYPE 70

6.3.1.1.1 SEMI AUTOMATED 70

6.3.1.1.2 AUTOMATED 70

6.3.1.2 INSTRUMENTS, PURCHASE TYPE 70

6.3.1.2.1 OUTRIGHT PURCHASE 70

6.3.1.2.2 RENTAL 70

6.4 SOFTWARE & SERVICES 71

7 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY 72

7.1 OVERVIEW 73

7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 75

7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM 77

7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI) 77

7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA) 77

7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA) 77

7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS 77

7.2.2.1 FIRST-GENERATION ELISA 77

7.2.2.2 SECOND-GENERATION ELISA 77

7.2.2.3 THIRD-GENERATION ELISA 77

7.2.2.4 FOURTH-GENERATION ELISA 77

7.3 RAPID TESTS 78

7.4 NEXT-GENERATION SEQUENCING (NGS) 79

7.5 NUCLEIC ACID TEST 80

7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 81

7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 81

7.6 WESTERN BLOT ASSAY 82

7.7 OTHERS 83

8 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE 84

8.1 OVERVIEW 85

8.2 ONCOLOGY 87

8.3 DIABETES MELLITUS 88

8.4 COLD & FLU 89

8.5 CHOLESTEROL 90

8.6 INFECTIOUS DISEASES 91

8.7 RESPIRATORY DISEASES 92

8.8 HIV/AIDS 93

8.9 OTHERS 94

9 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER 95

9.1 OVERVIEW 96

9.2 DIAGNOSTIC CENTERS 98

9.3 BLOOD BANK 99

9.4 HOSPITALS 100

9.5 CLINICS 101

9.6 AMBULATORY SURGICAL CENTERS 102

10 NORTH AMERICA BLOOD SCREENING MARKET, BY GEOGRAPHY 103

10.1 NORTH AMERICA 103

10.1.1 U.S. 114

10.1.2 CANADA 121

10.1.3 MEXICO 128

11 NORTH AMERICA BLOOD SCREENING MARKET, COMPANY LANDSCAPE 135

11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 135

12 COMPANY PROFILES 136

12.1 F. HOFFMANN-LA ROCHE LTD 136

12.1.1 COMPANY OVERVIEW 136

12.1.2 REVENUEANALYSIS 136

12.1.3 COMPANY SHARE ANALYSIS 137

12.1.4 PRODUCT PORTFOLIO 137

12.1.5 RECENT DEVELOPMENT 138

12.2 ABBOTT 139

12.2.1 COMPANY OVERVIEW 139

12.2.2 REVENUE ANALYSIS 139

12.2.3 COMPANY SHAREV ANALYSIS 140

12.2.4 PRODUCT PORTFOLIO 140

12.2.5 RECENT DEVELOPMENT 141

12.3 THERMO FISHER SCIENTIFIC INC. 142

12.3.1 COMPANY OVERVIEW 142

12.3.2 REVENUE ANALYSIS 142

12.3.3 COMPANY SHAREV ANALYSIS 143

12.3.4 PRODUCT PORTFOLIO 143

12.3.5 RECENT DEVELOPMENTS 144

12.4 SIEMENS AG 145

12.4.1 COMPANY OVERVIEW 145

12.4.2 REVENUE ANALYSIS 145

12.4.3 COMPANY SHAREV ANALYSIS 146

12.4.4 PRODUCT PORTFOLIO 146

12.4.5 RECENT DEVELOPMENTS 148

12.5 BIO-RAD LABORATORIES, INC. 149

12.5.1 1.3.1COMPANY OVERVIEW 149

12.5.2 REVENUE ANALYSIS 149

12.5.3 COMPANY SHAREV ANALYSIS 150

12.5.4 PRODUCT PORTFOLIO 150

12.5.5 RECENT DEVELOPMENTS 152

12.6 BD 153

12.6.1 COMPANY OVERVIEW 153

12.6.2 REVENUE ANALYSIS 153

12.6.3 PRODUCT PORTFOLIO 154

12.6.4 RECENT DEVELOPMENTS 154

12.7 BECKMAN COULTER, INC. 155

12.7.1 COMPANY OVERVIEW 155

12.7.2 GEOGRAPHICPRESENCE 155

12.7.3 PODUCT PORTFOLIO 156

12.7.4 RECENET DEVELOPEMENTS 157

12.8 BIOMERIEUX SA 158

12.8.1 COMPANY OVERVIEW 158

12.8.2 REVENUE ANALYSIS 158

12.8.3 PRODUCT PORTFOLIO 159

12.8.4 RECENT DEVELOPMENT 160

12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION) 161

12.9.1 COMPANY OVERVIEW 161

12.9.2 GEOGRAPHIC PRESENCE 161

12.9.3 PRODUCT PORTFOLIO 162

12.9.4 RECENT DEVELOPMENT 163

12.10 ENZO BIOCHEM INC. 164

12.10.1 COMPANY OVERVIEW 164

12.10.2 REVENUE ANALYSIS 164

12.10.3 PRODUCT PORTFOLIO 165

12.10.4 RECENT DEVELOPMENTS 166

12.11 GRIFOLS INTERNATIONAL, S.A. 167

12.11.1 COMPANY OVERVIEW 167

12.11.2 REVENUE ANALYSIS 167

12.11.3 PRODUCT PORTFOLIO 168

12.11.4 RECENT DEVELOPMENTS 169

12.12 HOLOGIC INC. 170

12.12.1 COMPANY OVERVIEW 170

12.12.2 REVENUE ANALYSIS 170

12.12.3 PRODUCT PORTFOLIO 171

12.12.4 RECENT DEVELOPMENTS 171

12.13 IMMUCOR, INC. 172

12.13.1 COMPANY OVERVIEW 172

12.13.2 GEOGRAPHIC PRESENCE: 172

12.13.3 PRODUCT PORTFOLIO 173

12.13.4 RECENT DEVELOPMENTS 174

12.14 MERIDIAN BIOSCIENCE, INC. 175

12.14.1 COMPANY OVERVIEW 175

12.14.2 REVENUE ANALYSIS 175

12.14.3 PRODUCT PORTFOLIO 176

12.14.4 RECENT DEVELOPMENTS 177

12.15 ORTHO CLINICAL DIAGNOSTICS 178

12.15.1 COMPANY OVERVIEW 178

12.15.2 GEOGRAPHIC PRESENCE 178

12.15.3 PRODUCT PORTFOLIO 179

12.15.4 RECENT DEVELOPMENTS 180

13 RELATED REPORTS 181

LIST OF FIGURES

FIGURE 1 NORTH AMERICA BLOOD SCREENING MARKET: SEGMENTATION 19

FIGURE 2 NORTH AMERICA BLOOD SCREENING MARKET: DATA TRIANGULATION 22

FIGURE 3 NORTH AMERICA BLOOD SCREENING MARKET: DROC ANALYSIS 23

FIGURE 4 NORTH AMERICA BLOOD SCREENING MARKET:BOTTOM UP APPROACH 24

FIGURE 5 NORTH AMERICA BLOOD SCREENING MARKET:TOP DOWN APPROACH 24

FIGURE 6 NORTH AMERICA BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS 25

FIGURE 7 NORTH AMERICA BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID 26

FIGURE 8 NORTH AMERICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 27

FIGURE 9 NORTH AMERICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 28

FIGURE 10 NORTH AMERICA BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX 29

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA BLOOD SCREENING MARKET 32

FIGURE 12 NORTH AMERICA BLOOD SCREENING MARKET: SEGMENTATION 41

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 42

FIGURE 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 43

FIGURE 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 44

FIGURE 16 NORTH AMERICA BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 46

FIGURE 17 NORTH AMERICA BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 57

?

FIGURE 18 NORTH AMERICA BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 69

FIGURE 19 NORTH AMERICA BLOOD SCREENING MARKET: BY END USER, 2017 80

FIGURE 20 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) 87

FIGURE 21 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) 88

FIGURE 22 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 88

FIGURE 23 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) 89

FIGURE 24 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) 89

FIGURE 25 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) 119

LIST OF TABLES

TABLE 1 LIST OF PRICES FOR FEW DEVICES 37

TABLE 2 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) 48

TABLE 3 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 49

TABLE 4 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 50

TABLE 5 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 51

TABLE 6 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 52

TABLE 7 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 54

TABLE 8 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 54

TABLE 9 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 55

TABLE 10 NORTH AMERICA SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 56

TABLE 11 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 59

TABLE 12 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 60

TABLE 13 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 61

TABLE 14 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) 61

TABLE 15 NORTH AMERICA RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 63

TABLE 16 NORTH AMERICA NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 64

TABLE 17 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 65

TABLE 18 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 65

TABLE 19 NORTH AMERICA WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 67

TABLE 20 NORTH AMERICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 68

TABLE 21 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 71

TABLE 22 NORTH AMERICA ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 72

TABLE 23 NORTH AMERICA DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 73

TABLE 24 NORTH AMERICA COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 74

TABLE 25 NORTH AMERICA CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 75

TABLE 26 NORTH AMERICA INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 76

TABLE 27 NORTH AMERICA RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 77

TABLE 28 NORTH AMERICA HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 78

TABLE 29 NORTH AMERICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 79

TABLE 30 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 82

TABLE 31 NORTH AMERICA DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 83

TABLE 32 NORTH AMERICA BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 84

TABLE 33 NORTH AMERICA HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 85

TABLE 34 NORTH AMERICA CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 86

TABLE 35 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 87

TABLE 36 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 91

TABLE 37 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 91

TABLE 38 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 93

TABLE 39 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 93

TABLE 40 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET,BY REAGENTS & KITS, 2016-2025 (USD MILLION) 94

TABLE 41 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 94

TABLE 42 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 95

TABLE 43 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 95

TABLE 44 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 96

TABLE 45 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 96

TABLE 46 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 97

TABLE 47 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 97

TABLE 48 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 98

TABLE 49 U.S. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 99

TABLE 50 U.S. REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 99

TABLE 51 U.S. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 100

TABLE 52 U.S. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 100

TABLE 53 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 101

TABLE 54 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 101

TABLE 55 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 102

TABLE 56 U.S. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 102

TABLE 57 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 103

TABLE 58 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 103

TABLE 59 U.S. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 104

TABLE 60 U.S. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 105

TABLE 61 CANADA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 106

TABLE 62 CANADA REAGENTS & KITS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 106

TABLE 63 CANADA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 107

TABLE 64 CANADA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 108

TABLE 65 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 108

TABLE 66 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 109

TABLE 67 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 109

TABLE 68 CANADA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 110

TABLE 69 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 110

TABLE 70 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 111

TABLE 71 CANADA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 111

TABLE 72 CANADA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 112

TABLE 73 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 113

TABLE 74 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 113

TABLE 75 MEXICO ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 114

TABLE 76 MEXICO NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 115

TABLE 77 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 115

TABLE 78 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 116

TABLE 79 MEXICO BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 116

TABLE 80 MEXICO NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 117

TABLE 81 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 117

TABLE 82 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 118

TABLE 83 MEXICO BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) 118

TABLE 84 MEXICO BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 119

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.

select a license
Single User License
USD 2500 INR 181375
Corporate User License
USD 3200 INR 232160

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com